4410

    507789

    JAGSNPHARM

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    JAGSONPAL PHARMACEUTICALS Share Price Today

    JAGSONPAL PHARMACEUTICALS is currently trading at ₹224.08, down by ₹2.78 from the previous close. The stock touched an intraday high of ₹232.21 and a low of ₹223.01 during the latest trading session. Over the past one year, JAGSONPAL PHARMACEUTICALS has delivered a loss of 7.88%, while the stock has gained 8.41% in the last one month.

    JAGSONPAL PHARMACEUTICALS performance

    Today’s low Today’s high
    ₹ 223.01 ₹ 232.21
    ₹ 224.08
    52 week low 52 week high
    ₹ 155.00 ₹ 301.65
    ₹ 224.08
    Open Price ₹ 226.42
    Prev. Close ₹ 226.87
    Volume (Shares) 33634.00
    Total traded value ₹ 75.36
    Upper Circuit ₹ 272.24
    Lower Circuit ₹ 181.50
    info

    Investment Returns

    Over 1 Month 8.41% Over 3 Months 16.65% Over 6 Months 28.66% Over 1 Year -7.88%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    JAGSONPAL PHARMACEUTICALS fundamentals


    • Market cap (Cr) 1,477.30
    • P/E Ratio (TTM) 34.78
    • Beta 0.57
    • Book Value / share 41.85
    • Return on equity 18.58%
    • EPS (TTM) 6.77
    • Dividend yield 1.79%
    • Net profit/quarter (Cr) 8.76
    info icon alternate text
    • Market cap (Cr) 1,477.10
    • P/E Ratio (TTM) 34.78
    • Beta 0.51
    • Book Value / share 41.85
    • Return on equity 18.58%
    • EPS (TTM) 6.77
    • Dividend yield 1.79%
    • Net profit/quarter (Cr) 8.76
    info icon alternate text

    JAGSONPAL PHARMACEUTICALS Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 64.20
    Operating Expense 55.61
    Net Profit 8.76
    Net Profit Margin (%) 13.64
    Earnings Per Share (EPS) 1.25
    EBITDA 14.33
    Effective Tax Rate (%) 25.42
    Particulars DEC 2025 (Values in Cr)
    Revenue 72.95
    Operating Expense 59.32
    Net Profit 10.95
    Net Profit Margin (%) 15.01
    Earnings Per Share (EPS) 1.67
    EBITDA 17.16
    Effective Tax Rate (%) 24.58
    Particulars SEP 2025 (Values in Cr)
    Revenue 74.47
    Operating Expense 60.69
    Net Profit 12.57
    Net Profit Margin (%) 16.87
    Earnings Per Share (EPS) 1.88
    EBITDA 19.47
    Effective Tax Rate (%) 25.22
    Particulars JUN 2025 (Values in Cr)
    Revenue 75.61
    Operating Expense 64.00
    Net Profit 10.80
    Net Profit Margin (%) 14.28
    Earnings Per Share (EPS) 1.60
    EBITDA 17.03
    Effective Tax Rate (%) 25.22
    Particulars MAR 2025 (Values in Cr)
    Revenue 58.56
    Operating Expense 52.41
    Net Profit 6.58
    Net Profit Margin (%) 11.23
    Earnings Per Share (EPS) 0.98
    EBITDA 11.28
    Effective Tax Rate (%) 24.45
    Particulars MAR 2026 (Values in Cr)
    Revenue 287.23
    Operating Expense 239.63
    Net Profit 43.08
    Net Profit Margin (%) 14.99
    Earnings Per Share (EPS) 6.40
    EBITDA 67.99
    Effective Tax Rate (%) 25.10
    Particulars MAR 2025 (Values in Cr)
    Revenue 268.72
    Operating Expense 226.74
    Net Profit 55.36
    Net Profit Margin (%) 20.60
    Earnings Per Share (EPS) 8.26
    EBITDA 78.94
    Effective Tax Rate (%) 20.75
    Particulars MAR 2024 (Values in Cr)
    Revenue 208.70
    Operating Expense 188.11
    Net Profit 22.46
    Net Profit Margin (%) 10.76
    Earnings Per Share (EPS) 8.49
    EBITDA 32.33
    Effective Tax Rate (%) 24.80
    Particulars MAR 2023 (Values in Cr)
    Revenue 236.71
    Operating Expense 204.18
    Net Profit 26.72
    Net Profit Margin (%) 11.28
    Earnings Per Share (EPS) 10.20
    EBITDA 36.43
    Effective Tax Rate (%) 23.24
    Particulars MAR 2022 (Values in Cr)
    Revenue 217.58
    Operating Expense 194.37
    Net Profit 18.86
    Net Profit Margin (%) 8.66
    Earnings Per Share (EPS) 7.20
    EBITDA 28.46
    Effective Tax Rate (%) 29.24
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 36.08
    ROE % 18.58
    ROCE % 22.82
    Total Debt to Total Equity 0.04
    EBITDA Margin 22.05
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 70.88
    ROE % 12.97
    ROCE % 16.89
    Total Debt to Total Equity 0.04
    EBITDA Margin 15.50
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 60.65
    ROE % 18.32
    ROCE % 23.48
    Total Debt to Total Equity 0.02
    EBITDA Margin 15.39
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 50.68
    ROE % 15.28
    ROCE % 21.14
    Total Debt to Total Equity 0.03
    EBITDA Margin 13.08
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 43.55
    ROE % 15.70
    ROCE % 19.57
    Total Debt to Total Equity 0.05
    EBITDA Margin 12.49
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 128.73
    Total Assets 278.26
    Total Liabilities 278.26
    Total Equity 239.95
    Share Outstanding 6
    Price to Book Ratio 5.99
    Return on Assets (%) 19.89
    Return on Capital (%) 23.07
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 147.93
    Total Assets 217.07
    Total Liabilities 217.07
    Total Equity 187.40
    Share Outstanding 2
    Price to Book Ratio 3.95
    Return on Assets (%) 10.34
    Return on Capital (%) 11.99
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 114.62
    Total Assets 194.94
    Total Liabilities 194.94
    Total Equity 158.89
    Share Outstanding 2
    Price to Book Ratio 4.78
    Return on Assets (%) 13.70
    Return on Capital (%) 16.82
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 25.24
    Total Assets 164.22
    Total Liabilities 164.22
    Total Equity 132.75
    Share Outstanding 2
    Price to Book Ratio 6.19
    Return on Assets (%) 11.48
    Return on Capital (%) 14.2
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 60.22
    Total Assets 164.20
    Total Liabilities 164.20
    Total Equity 121.92
    Share Outstanding 2
    Price to Book Ratio 1.83
    Return on Assets (%) 10.38
    Return on Capital (%) 13.25
    Particulars MAR 2025 (Values in Cr)
    Net Income 69.85
    Cash from Operations 63.44
    Cash from Investing -45.14
    Cash from Financing -11.69
    Net change in Cash -1.54
    Free Cash Flow 63.79
    Particulars MAR 2024 (Values in Cr)
    Net Income 29.86
    Cash from Operations 43.67
    Cash from Investing -24.54
    Cash from Financing -8.91
    Net change in Cash 1.70
    Free Cash Flow 43.92
    Particulars MAR 2023 (Values in Cr)
    Net Income 34.80
    Cash from Operations 53.93
    Cash from Investing -57.67
    Cash from Financing -0.45
    Net change in Cash -11.47
    Free Cash Flow 54.24
    Particulars MAR 2022 (Values in Cr)
    Net Income 26.64
    Cash from Operations 13.78
    Cash from Investing -25.77
    Cash from Financing -17.55
    Net change in Cash -36.41
    Free Cash Flow 14.83
    Particulars MAR 2021 (Values in Cr)
    Net Income 21.87
    Cash from Operations 31.37
    Cash from Investing -2.26
    Cash from Financing -6.82
    Net change in Cash 19.12
    Free Cash Flow 31.84
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 31.09 12.90 1.50 238.25 23.12 38.85
    BLISS GVS PHARMA LTD 503.85 40.50 4.47 5343.64 118.35 552.90
    CIPLA LTD 1429.45 30.34 3.35 115477.45 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 459.95 20.29 3.32 1353.68 256.40 480.00
    GLAXOSMITHKLINE PHARMA LT 2506.70 44.13 18.72 42465.01 2088.00 3217.10
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 31.09 21.74 4.00 238.25 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 534.05 23.94 4.17 1543.97 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8092.00 105.68 23.17 20230.00 7630.00 9850.00
    BLISS GVS PHARMA LTD 503.85 54.47 4.62 5343.64 118.35 552.90

    JAGSONPAL PHARMACEUTICALS shareholding pattern

    Holding
    28.03%
    69.04%
    2.29%
    0.62%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    JAGSONPAL PHARMACEUTICALS Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    224.08 -1.22 redarrow
    red-green-graph indicator
    10 Bearish
    6 Bullish
    • 5 Days 227.70
    • 26 Days 224.70
    • 10 Days 228.90
    • 50 Days 217.30
    • 12 Days 228.80
    • 100 Days 208.90
    • 20 Days 226.70
    • 200 Days 206.60
    226.05 PIVOT
    First Support 222.92 First Resistance 230.01 Second Support 218.96 Second Resistance 233.14 Third Support 215.83 Third Resistance 237.10
    RSI 52.89 ADX 50.44 MACD 4.11 Williams % R -87.76 Commodity Channel Index (CCI) -42.36
    Date 2026-07-16 Week 31108.00 Same Day 44516.00 Month 83877.00
    1 Year 0.58 3 Year 1.08
    Over 1 Month
    8.41% down
    Over 1 Year
    -7.88% down
    Over 3 Months
    16.65% down
    Over 3 Years
    16.26% down
    Over 6 Months
    28.66% down
    Over 5 Years
    27.55% down

    JAGSONPAL PHARMACEUTICALS Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    12 Sep 2025 2.5 Final 12 Sep 2025 Equity shares
    06 Sep 2024 5.0 Final 06 Sep 2024 Equity shares
    21 Aug 2023 5.0 Final 21 Aug 2023 Equity shares
    29 Oct 2021 4.0 Interim 01 Nov 2021 Equity shares
    22 Sep 2021 1.0 Final 24 Sep 2021 Equity shares
    22 Sep 2020 0.5 Final 24 Sep 2020 Equity shares
    20 Sep 2019 0.25 Final 24 Sep 2019 Equity shares
    18 Sep 2018 0.1 Final 21 Sep 2018 Equity shares
    21 Sep 2017 0.1 Final 23 Sep 2017 Equity shares
    21 Sep 2016 0.1 Final 23 Sep 2016 Equity shares
    21 Sep 2015 0.1 Final 23 Sep 2015 Equity shares
    25 Sep 2014 0.5 Final 27 Sep 2014 Equity shares
    25 Sep 2013 0.5 Final 27 Sep 2013 Equity shares
    21 Sep 2012 5.0 Final 25 Sep 2012 Equity shares
    23 Sep 2011 0.5 Final 27 Sep 2011 Equity shares
    21 Sep 2010 0.5 Final 23 Sep 2010 Equity shares
    23 Sep 2009 0.25 Final 25 Sep 2009 Equity shares
    24 Sep 2008 0.1 Final 26 Sep 2008 Equity shares
    21 Sep 2007 0.1 Final 25 Sep 2007 Equity shares
    26 Sep 2005 0.0 Final 28 Sep 2005 Equity shares
    Ex-Date Ex-Bonus Ratio
    28 Jul 2004 20 Jul 2004 3:1
    Ex-Date Old FV NEW FV Record Date
    08 Jan 2025 5.0 2.0 08 Jan 2025
    20 Jul 2004 10.0 5.0 28 Jul 2004
    Dividend date Dividend amount Dividend type Record date Instrument type
    12 Sep 2025 2.5 Final 12 Sep 2025 Equity shares
    06 Sep 2024 5.0 Final 06 Sep 2024 Equity shares
    21 Aug 2023 5.0 Final 21 Aug 2023 Equity shares
    29 Oct 2021 4.0 Interim 01 Nov 2021 Equity shares
    22 Sep 2021 1.0 Final 24 Sep 2021 Equity shares
    22 Sep 2020 0.5 Final 24 Sep 2020 Equity shares
    20 Sep 2019 0.25 Final 24 Sep 2019 Equity shares
    18 Sep 2018 0.1 Final 21 Sep 2018 Equity shares
    21 Sep 2017 0.1 Final 23 Sep 2017 Equity shares
    21 Sep 2016 0.1 Final 23 Sep 2016 Equity shares
    21 Sep 2015 0.1 Final 23 Sep 2015 Equity shares
    25 Sep 2014 0.5 Final 27 Sep 2014 Equity shares
    25 Sep 2013 0.5 Final 27 Sep 2013 Equity shares
    21 Sep 2012 5.0 Final 25 Sep 2012 Equity shares
    23 Sep 2011 0.5 Final 27 Sep 2011 Equity shares
    21 Sep 2010 0.5 Final 23 Sep 2010 Equity shares
    23 Sep 2009 0.25 Final 25 Sep 2009 Equity shares
    24 Sep 2008 0.1 Final 26 Sep 2008 Equity shares
    21 Sep 2007 0.1 Final 25 Sep 2007 Equity shares
    26 Sep 2005 0.0 Final 28 Sep 2005 Equity shares
    Ex-Date Ex-Bonus Ratio
    28 Jul 2004 20 Jul 2004 3:1
    Ex-Date Old FV NEW FV Record Date
    08 Jan 2025 5.0 2.0 08 Jan 2025
    20 Jul 2004 10.0 5.0 28 Jul 2004

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Jagsonpal Pharmaceuticals Ltd?

    Answer Field

    Jagsonpal Pharmaceuticals Ltd share price is for NSE ₹ 224.08 & for BSE ₹ 224.25 as on Jul 17 2026 03:30 PM.

    What is the Market Cap of Jagsonpal Pharmaceuticals Ltd Share?

    Answer Field

    The market cap of Jagsonpal Pharmaceuticals Ltd for NSE ₹ 1,477.30 & for BSE ₹ 0.00 as on Jul 17 2026 03:30 PM.

    What is the 52 Week High and Low of Jagsonpal Pharmaceuticals Ltd?

    Answer Field

    The 52 Week High and Low of Jagsonpal Pharmaceuticals Ltd for NSE is ₹ 301.65 and ₹ 155.00 and for BSE is ₹ 301.80 and ₹ 154.90.

    What is 1 year return for Jagsonpal Pharmaceuticals Ltd?

    Answer Field

    The 1 year returns on the stock has been -7.88%.

    What is the P/E Ratio of Jagsonpal Pharmaceuticals Ltd Share?

    Answer Field

    As on Jul 17 2026 03:30 PM the price-to-earnings (PE) ratio for Jagsonpal Pharmaceuticals Ltd share is 34.78.

    What is the PB ratio of Jagsonpal Pharmaceuticals Ltd Share?

    Answer Field

    As on Jul 17 2026 03:30 PM, the price-to-book (PB) ratio for Jagsonpal Pharmaceuticals Ltd share is 41.85.

    How to Buy Jagsonpal Pharmaceuticals Ltd Share?

    Answer Field

    You can trade in Jagsonpal Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Jagsonpal Pharmaceuticals Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Jagsonpal Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Jagsonpal Pharmaceuticals Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |